A 56-year-old client with suspected leukemia is scheduled for a bone marrow biopsy this morning. During the pre-procedure assessment, the nurse reviews the client's laboratory results and current medications. Which assessment finding would be most important for the nurse to report to the healthcare provider before the procedure?

A platelet count of 45,000/mm³ indicates severe thrombocytopenia, posing the highest bleeding risk during an invasive bone marrow biopsy. Other lab abnormalities (low Hgb, low WBC, normal INR) are less critical for immediate pre-procedure safety.

Core Nursing Explanation Key Concept Analysis: This question assesses the nurse's ability to prioritize patient safety by identifying the greatest immediate risk before an invasive procedure. The core theme is bleeding risk assessment for a bone marrow biopsy. While leukemia often causes pancytopenia (low counts of all blood cells), the procedure's invasiveness makes thrombocytopenia (low platelet count) the most critical pre-procedural concern due to the risk of uncontrolled bleeding and hematoma formation at the biopsy site.

Answer Rationale: Key Point! A platelet count of 45,000/mm³ represents severe thrombocytopenia. Platelets are essential for primary hemostasis (clot formation). For an invasive procedure like a bone marrow biopsy, which involves puncturing the bone (often the posterior iliac crest) with a large-bore needle, a significantly low platelet count is the single most important modifiable risk factor for serious bleeding. This finding must be reported to the healthcare provider, as a platelet transfusion may be required before proceeding to ensure safety.

Distractor Analysis:
Watch out for confusion! Option ①: A Hemoglobin (Hgb) of 8.5 g/dL indicates anemia, which is common in leukemia. While important for the patient's overall condition and oxygen-carrying capacity, it does not directly increase the procedural bleeding risk in the same way thrombocytopenia does. The provider would be aware of this chronic issue.
Option ③: A White Blood Cell (WBC) count of 2,500/mm³ indicates leukopenia/neutropenia, increasing infection risk. However, a bone marrow biopsy is a sterile procedure. The immediate, procedure-related safety threat is bleeding, not infection, making this less critical to report *before* the procedure.
Option ④: An International Normalized Ratio (INR) of 1.2 is within the normal therapeutic range (typically 0.8-1.2 for someone not on anticoagulants). This indicates normal clotting factor function and does not suggest an increased bleeding risk.

Related Concepts: The nursing priority follows the ABC (Airway, Breathing, Circulation) framework, where uncontrolled bleeding is a direct threat to Circulation. For invasive procedures, always assess coagulation status (platelets, PT/INR, aPTT) first. In pancytopenia, prioritize risks: bleeding (platelets) > infection (WBC) > symptoms of anemia (Hgb). Concept Summary

Concept	Key Takeaway
Bone Marrow Biopsy	Invasive diagnostic procedure for hematologic disorders. Primary nursing concern: bleeding risk.
Thrombocytopenia	Platelet count < 150,000/mm³. Counts < 50,000/mm³ significantly increase procedure-related bleeding risk.
Pancytopenia	Low RBCs, WBCs, and Platelets. Common in leukemia. Requires risk prioritization.
Pre-procedure Assessment	Focus on modifiable risks that threaten immediate safety during/after the procedure.

Side-by-Side Comparison!

Lab Value Abnormality	Primary Risk	Implication for Invasive Procedure	Nursing Priority
Low Platelets (e.g., 45,000/mm³)	Bleeding/Hematoma	HIGHEST immediate risk. May require platelet transfusion pre-procedure.	Report immediately. Monitor site for bleeding post-procedure.
Low Hemoglobin (e.g., 8.5 g/dL)	Anemia, Fatigue, Hypoxia	Patient may tolerate procedure poorly but does not directly cause bleeding. Chronic issue.	Monitor for dizziness, provide support, but not an absolute contraindication.
Low WBC (e.g., 2,500/mm³)	Infection	Risk is post-procedure infection. The procedure itself is sterile.	Meticulous sterile technique. Monitor for fever/signs of infection afterwards.
Elevated INR (e.g., >1.5)	Bleeding (clotting factor deficiency)	High risk, similar to thrombocytopenia.	Report immediately. Procedure may be delayed.

Anatomy, Physiology & Pharmacology Points Physiology: Platelets initiate the hemostatic plug. A count below 50,000/mm³ impairs this process. Bone marrow is highly vascular, so biopsy sites can bleed profusely.
Pharmacology: If a platelet transfusion is ordered pre-procedure, remember: platelets are stored at room temperature, infused rapidly (usually over 15-30 minutes), and require careful monitoring for transfusion reactions (fever, chills, allergic response). Memory Tips Mnemonic: "P Before I" – Before an invasive procedure, check Platelets (bleeding risk) before Infection risk (WBC).
Critical Threshold: Remember the "50k rule" – Platelet counts < 50,000/mm³ pose a significant bleeding risk for procedures. High-Frequency NCLEX Topics Prioritizing lab values based on patient situation is a classic NCLEX strategy. The exam tests your ability to distinguish between chronic management issues (anemia) and acute safety threats (bleeding risk). Always ask: "What is the greatest immediate threat to this patient's safety *right now* given the planned intervention?" Watch Out for Question Variations! * Variation 1: "Which lab value requires immediate intervention?" Answer remains low platelets. * Variation 2: "The nurse is preparing to administer a platelet transfusion. Which finding indicates a transfusion reaction?" (Answer: Fever, chills, urticaria). * Variation 3: Shift to post-procedure care: "After a bone marrow biopsy on a client with thrombocytopenia, which finding requires immediate nursing action?" (Answer: Persistent oozing or expanding hematoma at the site).

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on an oncology unit. Mr. Johnson, 56, was admitted for fatigue and bruising. He is scheduled for a bone marrow biopsy at 10:00 AM to confirm suspected Acute Myeloid Leukemia (AML). During your morning assessment and chart review, you note his latest CBC: Hgb 8.5, WBC 2.5, Platelets 45.

Nursing Intervention Strategy: 1. Assessment & Communication: Immediately call the hematologist or provider covering the procedure. Report: "Mr. Johnson's pre-procedure labs show platelets at 45,000. Requesting guidance regarding bleeding risk for his scheduled bone marrow biopsy." Document the communication. 2. Pre-Procedure: If a platelet transfusion is ordered, administer it as per protocol. Re-check the platelet count post-transfusion as ordered. Continue to monitor for signs of active bleeding (petechiae, gum bleeding). 3. Procedure Support: Assist the provider with the biopsy. Ensure a pressure dressing is applied firmly to the site (posterior iliac crest). Have extra gauze and pressure supplies readily available. 4. Post-Procedure: Instruct the client to lie on the biopsy site for 30-60 minutes to apply direct pressure. Monitor the site every 15 minutes initially for bleeding or hematoma. Assess for pain and administer analgesics as ordered.

Patient Safety and Precautions: * Contraindication: Do not proceed with the biopsy without notifying the provider of critical thrombocytopenia. It is not an absolute contraindication, but the risk must be acknowledged and mitigated. * Medication Caution: Review the medication list for any anticoagulants (warfarin, heparin, DOACs) or antiplatelets (aspirin, clopidogrel). These may need to be held, but that is the provider's decision. * Key Monitoring: Post-biopsy, frequent vital signs and site checks are crucial. A falling blood pressure or tachycardia could indicate internal bleeding. Nursing Procedure & Medication Flow Pre-Biopsy Platelet Transfusion (if ordered): 1. Verify order and consent. 2. Obtain platelets from blood bank; check against patient ID with a second nurse. 3. Use appropriate IV tubing with a filter. 4. Infuse as ordered (usually 1 unit over 15-30 min). 5. Monitor closely for reactions: febrile non-hemolytic (most common), allergic, or more severe reactions. 6. Document vitals pre, during, and post-transfusion. A Word from Your Senior Nurse In the real world, you are the last safety check before a procedure. Never assume the provider has seen the latest labs. A quick scan for platelets and INR before any invasive procedure is a lifesaving habit. When you call the provider, be clear, concise, and state the problem and what you need: "Lab value X is critical for procedure Y. What are your orders?" This demonstrates critical thinking and protects your patient. On the NCLEX, they are testing this exact vigilance—the ability to see the red flag that could cause the most immediate harm.